EMOL Health, in partnership with Michigan State University College of Nursing and Diplomat Specialty Pharmacy, has started a project to improve adherence and compliance to Tarceva (Erlotinib). To achieve this goal, patients will be supplied with a Symptom Management Toolkit (SMT) and called weekly via an Interactive Voice Response (IVR) system. The SMT in combination with the IVR has been shown to reduce hospitalization, reduce symptom burden, the number of overall symptoms, unscheduled clinic visits, ER visits, and increase quality of life.

Click here to learn more.